Arlington Partners’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,788
Closed -$38.7K 566
2022
Q4
$38.7K Buy
+2,788
New +$39.4K 0.01% 236

Other funds holding BCAT

Arlington Partners's BCAT Position: Q1 2023 in Review

Arlington Partners sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q1 2023, closing a stake of 2,788 shares — an estimated $38.7K sold.

Arlington Partners first reported a position in BCAT in Q4 2022 and held it in 1 quarter. The position peaked at $38.7K in Q4 2022. 72 funds tracked by Wall St. Rank hold BCAT as of Q1 2023.

  • Arlington Partners reported no remaining BlackRock Capital Allocation Term Trust position as of Q1 2023 after selling out during the quarter.
  • Arlington Partners sold 2,788 BlackRock Capital Allocation Term Trust shares in Q1 2023, an estimated $38.7K.
  • Arlington Partners first reported a position in BlackRock Capital Allocation Term Trust in Q4 2022 and held it in 1 quarter.
  • Arlington Partners's BlackRock Capital Allocation Term Trust position peaked at $38.7K in Q4 2022.
  • 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2023.

Based on Arlington Partners's 13F filing for Q1 2023, filed 26 Apr 2023.